Rheumatoid interstitial lung disease in Canterbury New Zealand: prevalence, risk factors and long-term outcomes-protocol for a population-based retrospective study.

ABSTRACT:

Introduction

Rheumatoid arthritis (RA) affects approximately 0.5%-1% of the general population. Clinically significant interstitial lung diseases (ILD) develops in just under 10% of people with RA, and subclinical disease is more common. Little is known about RA-ILD in New Zealand (NZ), or the number of persons with RA in Canterbury, NZ. This study aims to determine: (1) incidence and prevalence of RA, (2) incidence and prevalence of RA-ILD, (3) clinical characteristics and risk factors for the development of RA-ILD, (4) long-term outcomes of RA-ILD, in the population resident within the Canterbury District Health Board (CDHB) catchment area.

Methods and analysis

Persons aged 18 years of age and older, and resident in the region covered by the CDHB with RA as well as RA-ILD

SUBMITTER: Farquhar H 

PROVIDER: S-EPMC8983996 | biostudies-literature | 2022 Apr

REPOSITORIES: biostudies-literature